Health
Is Mark Cuban Wrong About Employers, PBMs and Drug Prices?
Mark Cuban has been chiding self-insured employers for a while, saying that they have more power to change healthcare than any politician. One has to only look at his tweets to know that he has asked employers to stop letting insurance companies and pharmacy benefit managers dictate what they can offer to employees. He has…
Revenue cycle management (RCM): A complete guide
Key takeaways: Efficient revenue cycle management is crucial to ensuring efficient hospital operations and building financial stability. RCM technology solutions allow healthcare organizations to increase cash flow and improve operational efficiency across the entire revenue cycle. Revenue cycle management tools from Experian Health utilize data-driven insights, automation and AI to optimize revenue cycles, while supporting…
The Primary Care Clinician of the Future Won’t Practice Alone: The Power of Scientific Partnerships
The next frontier in medicine won’t be defined by a single technology or treatment. It will be defined by how primary care is practiced. Today’s clinicians are asked to keep pace with accelerating science while managing rising patient demands and systemic inefficiencies, leaving even the most dedicated stretched thin. The answer isn’t to expect more…
AI technology in healthcare: How it’s transforming the industry
Key takeaways: Artificial intelligence (AI) is changing how healthcare organizations operate, but while most providers believe in its potential, adoption is uneven. As payers use AI to control costs, providers must apply the same technology to address rising claim denials and data quality challenges. Experian Health’s AI Advantage™ and Patient Access Curator™ help providers prevent…
Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs
This roundup is published monthly. It is meant to highlight some of healthcare’s recent hiring news and is not intended to be comprehensive. If you have news about an executive appointment, resignation or layoff that you would like to share for this roundup, please reach out to [email protected]. Hires Agentic AI startup Ascertain welcomed Molly…
Case Study: How Patient Estimates helped UTMC comply with Price Transparency Rules
“Experian Health helped us meet the compliance of the Price Transparency Rule. Without it, we would have been subject to large fines.” — Marianna Ross, Manager of Customer Services and Financial Counseling at UTMC Challenge Before 2020, UTMC, a leading Level 1 Trauma Center that serves patients across three states, relied on a manual, time-consuming…
Crothall Associates Pack Love into Suitcase Drive for Foster Children
Suzy Lohman felt compelled to act when she learned that foster children treated at Cincinnati Children’s Hospital Medical Center often lacked proper bags for their belongings. Inspired by a hospital newsletter request for suitcases, duffel bags, and backpacks, Suzy launched a drive among EVS employees to collect these essential items. Many foster children, she knew, relied…
MedCity Pivot Podcast: A Chat With AWS Chief Medical Officer Rowland Illing
The real value of data is in the insights that can be unearthed from it and the tools that can be developed by harnessing that data to generate those insights. This is where Amazon has strived to get life science companies and health systems’ data to run on their cloud and create data lakes from…
Reimagining patient access: AI at the epicenter of coordinated benefits management
Healthcare claims denials are on the rise, despite more than a decade of industry-wide technological advances aimed at improving claims management processes. However, in recent years, the introduction of artificial intelligence (AI) into the healthcare ecosystem has begun transforming how healthcare organizations manage patient access — and the entire revenue cycle. This article summarizes a…
Bayer Menopause Drug Lands FDA Approval, Bringing Competition to an Astellas Product
A Bayer drug that hits two central nervous system targets to treat moderate-to-severe menopause symptoms has FDA approval, introducing a new non-hormonal therapeutic option that may have an advantage over an Astellas Pharma product that has a two-year head start in this market. The Bayer drug, elinzanetant, is a small molecule formulated as a soft…